|
|
- 2017
Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health systemDOI: 10.18549/PharmPract.2017.02.946 Keywords: Pharmacogenetics, Genetic Testing, Pharmacists, Patient Acceptance of Health Care, Platelet Aggregation Inhibitors, Acute Coronary Syndrome, Cytochrome P-450 CYP2C19, United States Abstract: To assess the feasibility of clinical pharmacist-led CYP2C19 genotype-guided P2Y12 inhibitor antiplatelet drug therapy recommendations to cardiologists in an outpatient cardiology practice
|
